US 11890330
Endolysins active against Bacillus bacteria, pharmaceutical compositions, and methods relating thereto
granted A61KA61K38/162A61K38/47
Quick answer
US patent 11890330 (Endolysins active against Bacillus bacteria, pharmaceutical compositions, and methods relating thereto) held by United States of America as represented by the Secretary of the Air Force expires Mon Feb 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- United States of America as represented by the Secretary of the Air Force
- Grant date
- Tue Feb 06 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 5
- CPC classes
- A61K, A61K38/162, A61K38/47, A61K45/06, A61P